A Prospective, Randomized, Placebo-controlled, Double-blind Study to Assess the Efficacy of Bacillus Coagulans Unique IS2 on Improving Bowel Movement Characteristics, Gastrointestinal-related Symptoms and Quality of Life in Healthy Adult Participants
Clinical trial NCT05123664 · COMPLETED
Trial details
- NCT number
- NCT05123664
- Sponsor
- PepsiCo Global R&D
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2022-04-11
- Primary completion
- 2023-12-20
- Enrollment
- 143
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.